nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—Ethinyl Estradiol—prostate cancer	0.243	1	CrCtD
Desogestrel—polycystic ovary syndrome—Ethinyl Estradiol—prostate cancer	0.188	1	CpDpCtD
Desogestrel—SHBG—prostate cancer	0.0774	0.597	CbGaD
Desogestrel—ESR1—prostate cancer	0.0523	0.403	CbGaD
Desogestrel—ESR1—Estramustine—prostate cancer	0.0329	0.192	CbGbCtD
Desogestrel—SHBG—Estrone—prostate cancer	0.0293	0.171	CbGbCtD
Desogestrel—SHBG—Ethinyl Estradiol—prostate cancer	0.0262	0.153	CbGbCtD
Desogestrel—ESR1—Estrone—prostate cancer	0.0212	0.124	CbGbCtD
Desogestrel—ESR1—Ethinyl Estradiol—prostate cancer	0.0189	0.11	CbGbCtD
Desogestrel—SHBG—Estradiol—prostate cancer	0.0169	0.0983	CbGbCtD
Desogestrel—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.0152	0.0785	CrCrCtD
Desogestrel—ESR1—Conjugated Estrogens—prostate cancer	0.0139	0.081	CbGbCtD
Desogestrel—Quinestrol—Estramustine—prostate cancer	0.0136	0.0701	CrCrCtD
Desogestrel—Mestranol—Estramustine—prostate cancer	0.0136	0.0701	CrCrCtD
Desogestrel—Ethinyl Estradiol—Estramustine—prostate cancer	0.0129	0.0668	CrCrCtD
Desogestrel—ESR1—Estradiol—prostate cancer	0.0122	0.0711	CbGbCtD
Desogestrel—Quinestrol—Estrone—prostate cancer	0.0108	0.0557	CrCrCtD
Desogestrel—Mestranol—Estrone—prostate cancer	0.0108	0.0557	CrCrCtD
Desogestrel—Ethinyl Estradiol—Estrone—prostate cancer	0.0103	0.053	CrCrCtD
Desogestrel—Mestranol—Conjugated Estrogens—prostate cancer	0.00949	0.049	CrCrCtD
Desogestrel—Quinestrol—Conjugated Estrogens—prostate cancer	0.00949	0.049	CrCrCtD
Desogestrel—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.00904	0.0467	CrCrCtD
Desogestrel—Etonogestrel—Ethinyl Estradiol—prostate cancer	0.00887	0.0458	CrCrCtD
Desogestrel—Norelgestromin—Ethinyl Estradiol—prostate cancer	0.0084	0.0434	CrCrCtD
Desogestrel—Quinestrol—Estradiol—prostate cancer	0.00817	0.0422	CrCrCtD
Desogestrel—Mestranol—Estradiol—prostate cancer	0.00817	0.0422	CrCrCtD
Desogestrel—Mestranol—Ethinyl Estradiol—prostate cancer	0.00797	0.0412	CrCrCtD
Desogestrel—Quinestrol—Ethinyl Estradiol—prostate cancer	0.00797	0.0412	CrCrCtD
Desogestrel—Ethinyl Estradiol—Estradiol—prostate cancer	0.00778	0.0402	CrCrCtD
Desogestrel—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.00695	0.0359	CrCrCtD
Desogestrel—Danazol—Ethinyl Estradiol—prostate cancer	0.00642	0.0331	CrCrCtD
Desogestrel—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00558	0.0288	CrCrCtD
Desogestrel—Danazol—Prednisone—prostate cancer	0.00225	0.0116	CrCrCtD
Desogestrel—SHBG—semen—prostate cancer	0.00222	0.382	CbGeAlD
Desogestrel—SHBG—prostate gland—prostate cancer	0.000557	0.0959	CbGeAlD
Desogestrel—PGR—prostate gland—prostate cancer	0.000502	0.0864	CbGeAlD
Desogestrel—ESR1—prostate gland—prostate cancer	0.000392	0.0675	CbGeAlD
Desogestrel—PGR—epithelium—prostate cancer	0.000369	0.0635	CbGeAlD
Desogestrel—ESR1—epithelium—prostate cancer	0.000288	0.0496	CbGeAlD
Desogestrel—SHBG—bone marrow—prostate cancer	0.000287	0.0494	CbGeAlD
Desogestrel—ESR1—renal system—prostate cancer	0.000267	0.046	CbGeAlD
Desogestrel—SHBG—testis—prostate cancer	0.000245	0.0422	CbGeAlD
Desogestrel—PGR—testis—prostate cancer	0.000221	0.038	CbGeAlD
Desogestrel—ESR1—testis—prostate cancer	0.000173	0.0298	CbGeAlD
Desogestrel—PGR—lymph node—prostate cancer	0.00016	0.0276	CbGeAlD
Desogestrel—Levonorgestrel—SRD5A1—prostate cancer	0.000146	0.109	CrCbGaD
Desogestrel—ESR1—lymph node—prostate cancer	0.000125	0.0216	CbGeAlD
Desogestrel—Ethinyl Estradiol—AOX1—prostate cancer	0.000112	0.0842	CrCbGaD
Desogestrel—Quinestrol—ESR1—prostate cancer	7.76e-05	0.0583	CrCbGaD
Desogestrel—Gestodene—CYP3A5—prostate cancer	7.42e-05	0.0557	CrCbGaD
Desogestrel—Etonogestrel—SHBG—prostate cancer	6.96e-05	0.0523	CrCbGaD
Desogestrel—Allylestrenol—ESR1—prostate cancer	6.04e-05	0.0453	CrCbGaD
Desogestrel—Mestranol—ESR1—prostate cancer	5.88e-05	0.0442	CrCbGaD
Desogestrel—Norgestimate—ESR1—prostate cancer	5.44e-05	0.0408	CrCbGaD
Desogestrel—Levonorgestrel—SHBG—prostate cancer	4.93e-05	0.037	CrCbGaD
Desogestrel—Nausea—Flutamide—prostate cancer	4.86e-05	0.000994	CcSEcCtD
Desogestrel—Gastrointestinal pain—Bicalutamide—prostate cancer	4.85e-05	0.000992	CcSEcCtD
Desogestrel—Weight decreased—Mitoxantrone—prostate cancer	4.85e-05	0.000992	CcSEcCtD
Desogestrel—Headache—Estradiol valerate/Dienogest—prostate cancer	4.83e-05	0.000989	CcSEcCtD
Desogestrel—Fluid retention—Prednisone—prostate cancer	4.83e-05	0.000989	CcSEcCtD
Desogestrel—Diarrhoea—Cabazitaxel—prostate cancer	4.73e-05	0.000968	CcSEcCtD
Desogestrel—Urticaria—Bicalutamide—prostate cancer	4.71e-05	0.000964	CcSEcCtD
Desogestrel—Etonogestrel—ESR1—prostate cancer	4.7e-05	0.0353	CrCbGaD
Desogestrel—Abdominal pain—Bicalutamide—prostate cancer	4.69e-05	0.000959	CcSEcCtD
Desogestrel—Vomiting—Degarelix—prostate cancer	4.66e-05	0.000955	CcSEcCtD
Desogestrel—Rash—Degarelix—prostate cancer	4.63e-05	0.000947	CcSEcCtD
Desogestrel—Dermatitis—Degarelix—prostate cancer	4.62e-05	0.000946	CcSEcCtD
Desogestrel—Headache—Degarelix—prostate cancer	4.6e-05	0.000941	CcSEcCtD
Desogestrel—Nausea—Estradiol valerate/Dienogest—prostate cancer	4.58e-05	0.000938	CcSEcCtD
Desogestrel—Breast pain—Epirubicin—prostate cancer	4.56e-05	0.000934	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR2—prostate cancer	4.55e-05	0.0342	CrCbGaD
Desogestrel—Danazol—SHBG—prostate cancer	4.49e-05	0.0337	CrCbGaD
Desogestrel—Libido decreased—Capecitabine—prostate cancer	4.47e-05	0.000916	CcSEcCtD
Desogestrel—Vomiting—Cabazitaxel—prostate cancer	4.39e-05	0.000899	CcSEcCtD
Desogestrel—Hypersensitivity—Bicalutamide—prostate cancer	4.37e-05	0.000894	CcSEcCtD
Desogestrel—Hypertension—Goserelin—prostate cancer	4.36e-05	0.000893	CcSEcCtD
Desogestrel—Nausea—Degarelix—prostate cancer	4.36e-05	0.000892	CcSEcCtD
Desogestrel—Erythema multiforme—Estradiol—prostate cancer	4.35e-05	0.000891	CcSEcCtD
Desogestrel—Headache—Cabazitaxel—prostate cancer	4.33e-05	0.000886	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	4.33e-05	0.000885	CcSEcCtD
Desogestrel—Levonorgestrel—AR—prostate cancer	4.32e-05	0.0324	CrCbGaD
Desogestrel—Eye disorder—Estradiol—prostate cancer	4.3e-05	0.00088	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	4.27e-05	0.000874	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	4.23e-05	0.000866	CcSEcCtD
Desogestrel—Breast pain—Doxorubicin—prostate cancer	4.22e-05	0.000864	CcSEcCtD
Desogestrel—Migraine—Docetaxel—prostate cancer	4.22e-05	0.000863	CcSEcCtD
Desogestrel—Immune system disorder—Estradiol—prostate cancer	4.16e-05	0.000851	CcSEcCtD
Desogestrel—Ethinyl Estradiol—SHBG—prostate cancer	4.15e-05	0.0312	CrCbGaD
Desogestrel—Disturbance in sexual arousal—Capecitabine—prostate cancer	4.12e-05	0.000842	CcSEcCtD
Desogestrel—Nausea—Cabazitaxel—prostate cancer	4.1e-05	0.00084	CcSEcCtD
Desogestrel—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	4.1e-05	0.000839	CcSEcCtD
Desogestrel—Migraine—Capecitabine—prostate cancer	4.08e-05	0.000836	CcSEcCtD
Desogestrel—Alopecia—Estradiol—prostate cancer	4.07e-05	0.000832	CcSEcCtD
Desogestrel—Diarrhoea—Bicalutamide—prostate cancer	4.06e-05	0.00083	CcSEcCtD
Desogestrel—Nervous system disorder—Goserelin—prostate cancer	4.04e-05	0.000828	CcSEcCtD
Desogestrel—Mental disorder—Estradiol—prostate cancer	4.03e-05	0.000825	CcSEcCtD
Desogestrel—Nervous system disorder—Conjugated Estrogens—prostate cancer	4.01e-05	0.00082	CcSEcCtD
Desogestrel—Malnutrition—Estradiol—prostate cancer	4.01e-05	0.00082	CcSEcCtD
Desogestrel—Skin disorder—Goserelin—prostate cancer	4.01e-05	0.00082	CcSEcCtD
Desogestrel—Norethindrone—SHBG—prostate cancer	3.99e-05	0.03	CrCbGaD
Desogestrel—Urticaria—Ethinyl Estradiol—prostate cancer	3.98e-05	0.000815	CcSEcCtD
Desogestrel—Skin disorder—Conjugated Estrogens—prostate cancer	3.97e-05	0.000812	CcSEcCtD
Desogestrel—Abdominal pain—Ethinyl Estradiol—prostate cancer	3.96e-05	0.000811	CcSEcCtD
Desogestrel—Danazol—AR—prostate cancer	3.93e-05	0.0295	CrCbGaD
Desogestrel—Mood swings—Capecitabine—prostate cancer	3.93e-05	0.000804	CcSEcCtD
Desogestrel—Breast disorder—Docetaxel—prostate cancer	3.87e-05	0.000792	CcSEcCtD
Desogestrel—Alopecia—Mitoxantrone—prostate cancer	3.79e-05	0.000775	CcSEcCtD
Desogestrel—Fluid retention—Epirubicin—prostate cancer	3.78e-05	0.000774	CcSEcCtD
Desogestrel—Vomiting—Bicalutamide—prostate cancer	3.77e-05	0.000771	CcSEcCtD
Desogestrel—Breast disorder—Capecitabine—prostate cancer	3.75e-05	0.000767	CcSEcCtD
Desogestrel—Rash—Bicalutamide—prostate cancer	3.74e-05	0.000765	CcSEcCtD
Desogestrel—Dermatitis—Bicalutamide—prostate cancer	3.73e-05	0.000764	CcSEcCtD
Desogestrel—Headache—Bicalutamide—prostate cancer	3.71e-05	0.00076	CcSEcCtD
Desogestrel—Hypersensitivity—Ethinyl Estradiol—prostate cancer	3.69e-05	0.000756	CcSEcCtD
Desogestrel—Affect lability—Prednisone—prostate cancer	3.64e-05	0.000744	CcSEcCtD
Desogestrel—Levonorgestrel—CYP19A1—prostate cancer	3.62e-05	0.0271	CrCbGaD
Desogestrel—Neoplasm—Epirubicin—prostate cancer	3.6e-05	0.000737	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	3.53e-05	0.000722	CcSEcCtD
Desogestrel—Nausea—Bicalutamide—prostate cancer	3.52e-05	0.000721	CcSEcCtD
Desogestrel—Mood swings—Prednisone—prostate cancer	3.5e-05	0.000716	CcSEcCtD
Desogestrel—Fluid retention—Doxorubicin—prostate cancer	3.5e-05	0.000716	CcSEcCtD
Desogestrel—Hypertension—Estradiol—prostate cancer	3.46e-05	0.000708	CcSEcCtD
Desogestrel—Diarrhoea—Ethinyl Estradiol—prostate cancer	3.43e-05	0.000702	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	3.39e-05	0.000693	CcSEcCtD
Desogestrel—Gastrointestinal pain—Goserelin—prostate cancer	3.37e-05	0.00069	CcSEcCtD
Desogestrel—Erythema multiforme—Etoposide—prostate cancer	3.37e-05	0.00069	CcSEcCtD
Desogestrel—Weight increased—Docetaxel—prostate cancer	3.37e-05	0.00069	CcSEcCtD
Desogestrel—Weight decreased—Docetaxel—prostate cancer	3.35e-05	0.000686	CcSEcCtD
Desogestrel—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	3.34e-05	0.000684	CcSEcCtD
Desogestrel—Eye disorder—Etoposide—prostate cancer	3.33e-05	0.000682	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—prostate cancer	3.33e-05	0.000682	CcSEcCtD
Desogestrel—Levonorgestrel—ESR1—prostate cancer	3.33e-05	0.025	CrCbGaD
Desogestrel—Danazol—CYP19A1—prostate cancer	3.29e-05	0.0247	CrCbGaD
Desogestrel—Urticaria—Goserelin—prostate cancer	3.28e-05	0.000671	CcSEcCtD
Desogestrel—Weight increased—Capecitabine—prostate cancer	3.26e-05	0.000668	CcSEcCtD
Desogestrel—Abdominal pain—Goserelin—prostate cancer	3.26e-05	0.000667	CcSEcCtD
Desogestrel—Urticaria—Conjugated Estrogens—prostate cancer	3.24e-05	0.000664	CcSEcCtD
Desogestrel—Weight decreased—Capecitabine—prostate cancer	3.24e-05	0.000664	CcSEcCtD
Desogestrel—Abdominal pain—Conjugated Estrogens—prostate cancer	3.23e-05	0.000661	CcSEcCtD
Desogestrel—Hypertension—Mitoxantrone—prostate cancer	3.22e-05	0.00066	CcSEcCtD
Desogestrel—Immune system disorder—Etoposide—prostate cancer	3.22e-05	0.000659	CcSEcCtD
Desogestrel—Nervous system disorder—Estradiol—prostate cancer	3.21e-05	0.000656	CcSEcCtD
Desogestrel—Vomiting—Ethinyl Estradiol—prostate cancer	3.19e-05	0.000652	CcSEcCtD
Desogestrel—Norethindrone—CYP3A5—prostate cancer	3.18e-05	0.0239	CrCbGaD
Desogestrel—Skin disorder—Estradiol—prostate cancer	3.18e-05	0.00065	CcSEcCtD
Desogestrel—Rash—Ethinyl Estradiol—prostate cancer	3.16e-05	0.000647	CcSEcCtD
Desogestrel—Dermatitis—Ethinyl Estradiol—prostate cancer	3.16e-05	0.000646	CcSEcCtD
Desogestrel—Alopecia—Etoposide—prostate cancer	3.15e-05	0.000645	CcSEcCtD
Desogestrel—Headache—Ethinyl Estradiol—prostate cancer	3.14e-05	0.000643	CcSEcCtD
Desogestrel—Allylestrenol—CYP3A4—prostate cancer	3.08e-05	0.0231	CrCbGaD
Desogestrel—Hypersensitivity—Goserelin—prostate cancer	3.04e-05	0.000622	CcSEcCtD
Desogestrel—Danazol—ESR1—prostate cancer	3.03e-05	0.0227	CrCbGaD
Desogestrel—Hypersensitivity—Conjugated Estrogens—prostate cancer	3.01e-05	0.000616	CcSEcCtD
Desogestrel—Nausea—Ethinyl Estradiol—prostate cancer	2.98e-05	0.000609	CcSEcCtD
Desogestrel—Skin disorder—Mitoxantrone—prostate cancer	2.96e-05	0.000606	CcSEcCtD
Desogestrel—Weight increased—Prednisone—prostate cancer	2.91e-05	0.000595	CcSEcCtD
Desogestrel—Weight decreased—Prednisone—prostate cancer	2.89e-05	0.000591	CcSEcCtD
Desogestrel—Migraine—Epirubicin—prostate cancer	2.84e-05	0.000582	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—prostate cancer	2.84e-05	0.000582	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Estradiol—prostate cancer	2.82e-05	0.000578	CcSEcCtD
Desogestrel—Diarrhoea—Goserelin—prostate cancer	2.82e-05	0.000578	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR1—prostate cancer	2.8e-05	0.021	CrCbGaD
Desogestrel—Erythema multiforme—Docetaxel—prostate cancer	2.8e-05	0.000574	CcSEcCtD
Desogestrel—Diarrhoea—Conjugated Estrogens—prostate cancer	2.79e-05	0.000572	CcSEcCtD
Desogestrel—Eye disorder—Docetaxel—prostate cancer	2.77e-05	0.000567	CcSEcCtD
Desogestrel—Mood swings—Epirubicin—prostate cancer	2.74e-05	0.00056	CcSEcCtD
Desogestrel—Erythema multiforme—Capecitabine—prostate cancer	2.71e-05	0.000555	CcSEcCtD
Desogestrel—Eye disorder—Capecitabine—prostate cancer	2.68e-05	0.000549	CcSEcCtD
Desogestrel—Hypertension—Etoposide—prostate cancer	2.68e-05	0.000549	CcSEcCtD
Desogestrel—Immune system disorder—Docetaxel—prostate cancer	2.68e-05	0.000548	CcSEcCtD
Desogestrel—Gastrointestinal pain—Estradiol—prostate cancer	2.67e-05	0.000547	CcSEcCtD
Desogestrel—Affect lability—Doxorubicin—prostate cancer	2.63e-05	0.000539	CcSEcCtD
Desogestrel—Migraine—Doxorubicin—prostate cancer	2.63e-05	0.000539	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	2.62e-05	0.000537	CcSEcCtD
Desogestrel—Vomiting—Goserelin—prostate cancer	2.62e-05	0.000537	CcSEcCtD
Desogestrel—Alopecia—Docetaxel—prostate cancer	2.62e-05	0.000536	CcSEcCtD
Desogestrel—Breast disorder—Epirubicin—prostate cancer	2.61e-05	0.000535	CcSEcCtD
Desogestrel—Rash—Goserelin—prostate cancer	2.6e-05	0.000532	CcSEcCtD
Desogestrel—Dermatitis—Goserelin—prostate cancer	2.6e-05	0.000532	CcSEcCtD
Desogestrel—Vomiting—Conjugated Estrogens—prostate cancer	2.6e-05	0.000532	CcSEcCtD
Desogestrel—Urticaria—Estradiol—prostate cancer	2.6e-05	0.000532	CcSEcCtD
Desogestrel—Mental disorder—Docetaxel—prostate cancer	2.6e-05	0.000531	CcSEcCtD
Desogestrel—Immune system disorder—Capecitabine—prostate cancer	2.59e-05	0.000531	CcSEcCtD
Desogestrel—Abdominal pain—Estradiol—prostate cancer	2.58e-05	0.000529	CcSEcCtD
Desogestrel—Headache—Goserelin—prostate cancer	2.58e-05	0.000529	CcSEcCtD
Desogestrel—Malnutrition—Docetaxel—prostate cancer	2.58e-05	0.000528	CcSEcCtD
Desogestrel—Rash—Conjugated Estrogens—prostate cancer	2.58e-05	0.000527	CcSEcCtD
Desogestrel—Dermatitis—Conjugated Estrogens—prostate cancer	2.57e-05	0.000527	CcSEcCtD
Desogestrel—Headache—Conjugated Estrogens—prostate cancer	2.56e-05	0.000524	CcSEcCtD
Desogestrel—Alopecia—Capecitabine—prostate cancer	2.54e-05	0.000519	CcSEcCtD
Desogestrel—Mood swings—Doxorubicin—prostate cancer	2.53e-05	0.000518	CcSEcCtD
Desogestrel—Mental disorder—Capecitabine—prostate cancer	2.51e-05	0.000515	CcSEcCtD
Desogestrel—Malnutrition—Capecitabine—prostate cancer	2.5e-05	0.000511	CcSEcCtD
Desogestrel—Gastrointestinal pain—Mitoxantrone—prostate cancer	2.49e-05	0.00051	CcSEcCtD
Desogestrel—Skin disorder—Etoposide—prostate cancer	2.46e-05	0.000504	CcSEcCtD
Desogestrel—Nausea—Goserelin—prostate cancer	2.45e-05	0.000501	CcSEcCtD
Desogestrel—Nausea—Conjugated Estrogens—prostate cancer	2.43e-05	0.000497	CcSEcCtD
Desogestrel—Urticaria—Mitoxantrone—prostate cancer	2.42e-05	0.000495	CcSEcCtD
Desogestrel—Breast disorder—Doxorubicin—prostate cancer	2.42e-05	0.000495	CcSEcCtD
Desogestrel—Hypersensitivity—Estradiol—prostate cancer	2.41e-05	0.000493	CcSEcCtD
Desogestrel—Abdominal pain—Mitoxantrone—prostate cancer	2.41e-05	0.000493	CcSEcCtD
Desogestrel—Etonogestrel—CYP3A4—prostate cancer	2.4e-05	0.018	CrCbGaD
Desogestrel—Eye disorder—Prednisone—prostate cancer	2.39e-05	0.000489	CcSEcCtD
Desogestrel—Immune system disorder—Prednisone—prostate cancer	2.31e-05	0.000473	CcSEcCtD
Desogestrel—Weight increased—Epirubicin—prostate cancer	2.27e-05	0.000465	CcSEcCtD
Desogestrel—Weight decreased—Epirubicin—prostate cancer	2.26e-05	0.000463	CcSEcCtD
Desogestrel—Alopecia—Prednisone—prostate cancer	2.26e-05	0.000462	CcSEcCtD
Desogestrel—Hypersensitivity—Mitoxantrone—prostate cancer	2.24e-05	0.000459	CcSEcCtD
Desogestrel—Mental disorder—Prednisone—prostate cancer	2.24e-05	0.000458	CcSEcCtD
Desogestrel—Diarrhoea—Estradiol—prostate cancer	2.24e-05	0.000458	CcSEcCtD
Desogestrel—Hypertension—Docetaxel—prostate cancer	2.23e-05	0.000456	CcSEcCtD
Desogestrel—Malnutrition—Prednisone—prostate cancer	2.23e-05	0.000455	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Etoposide—prostate cancer	2.19e-05	0.000448	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	2.18e-05	0.000447	CcSEcCtD
Desogestrel—Norethindrone—CYP2C19—prostate cancer	2.16e-05	0.0162	CrCbGaD
Desogestrel—Hypertension—Capecitabine—prostate cancer	2.16e-05	0.000441	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.11e-05	0.000432	CcSEcCtD
Desogestrel—Weight increased—Doxorubicin—prostate cancer	2.1e-05	0.00043	CcSEcCtD
Desogestrel—Weight decreased—Doxorubicin—prostate cancer	2.09e-05	0.000428	CcSEcCtD
Desogestrel—Diarrhoea—Mitoxantrone—prostate cancer	2.08e-05	0.000427	CcSEcCtD
Desogestrel—Vomiting—Estradiol—prostate cancer	2.08e-05	0.000425	CcSEcCtD
Desogestrel—Gastrointestinal pain—Etoposide—prostate cancer	2.07e-05	0.000424	CcSEcCtD
Desogestrel—Nervous system disorder—Docetaxel—prostate cancer	2.06e-05	0.000423	CcSEcCtD
Desogestrel—Rash—Estradiol—prostate cancer	2.06e-05	0.000422	CcSEcCtD
Desogestrel—Dermatitis—Estradiol—prostate cancer	2.06e-05	0.000422	CcSEcCtD
Desogestrel—Headache—Estradiol—prostate cancer	2.05e-05	0.000419	CcSEcCtD
Desogestrel—Skin disorder—Docetaxel—prostate cancer	2.05e-05	0.000419	CcSEcCtD
Desogestrel—Urticaria—Etoposide—prostate cancer	2.01e-05	0.000412	CcSEcCtD
Desogestrel—Abdominal pain—Etoposide—prostate cancer	2e-05	0.00041	CcSEcCtD
Desogestrel—Nervous system disorder—Capecitabine—prostate cancer	2e-05	0.000409	CcSEcCtD
Desogestrel—Skin disorder—Capecitabine—prostate cancer	1.98e-05	0.000405	CcSEcCtD
Desogestrel—Nausea—Estradiol—prostate cancer	1.94e-05	0.000397	CcSEcCtD
Desogestrel—Vomiting—Mitoxantrone—prostate cancer	1.94e-05	0.000396	CcSEcCtD
Desogestrel—Hypertension—Prednisone—prostate cancer	1.92e-05	0.000393	CcSEcCtD
Desogestrel—Rash—Mitoxantrone—prostate cancer	1.92e-05	0.000393	CcSEcCtD
Desogestrel—Dermatitis—Mitoxantrone—prostate cancer	1.92e-05	0.000393	CcSEcCtD
Desogestrel—Headache—Mitoxantrone—prostate cancer	1.91e-05	0.000391	CcSEcCtD
Desogestrel—Erythema multiforme—Epirubicin—prostate cancer	1.89e-05	0.000387	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.88e-05	0.000385	CcSEcCtD
Desogestrel—Eye disorder—Epirubicin—prostate cancer	1.87e-05	0.000382	CcSEcCtD
Desogestrel—Hypersensitivity—Etoposide—prostate cancer	1.87e-05	0.000382	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Docetaxel—prostate cancer	1.82e-05	0.000372	CcSEcCtD
Desogestrel—Nausea—Mitoxantrone—prostate cancer	1.81e-05	0.00037	CcSEcCtD
Desogestrel—Immune system disorder—Epirubicin—prostate cancer	1.81e-05	0.00037	CcSEcCtD
Desogestrel—Nervous system disorder—Prednisone—prostate cancer	1.78e-05	0.000365	CcSEcCtD
Desogestrel—Alopecia—Epirubicin—prostate cancer	1.77e-05	0.000362	CcSEcCtD
Desogestrel—Skin disorder—Prednisone—prostate cancer	1.76e-05	0.000361	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Capecitabine—prostate cancer	1.76e-05	0.00036	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—prostate cancer	1.75e-05	0.000358	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—prostate cancer	1.75e-05	0.000358	CcSEcCtD
Desogestrel—Malnutrition—Epirubicin—prostate cancer	1.74e-05	0.000356	CcSEcCtD
Desogestrel—Diarrhoea—Etoposide—prostate cancer	1.73e-05	0.000355	CcSEcCtD
Desogestrel—Eye disorder—Doxorubicin—prostate cancer	1.73e-05	0.000354	CcSEcCtD
Desogestrel—Gastrointestinal pain—Docetaxel—prostate cancer	1.72e-05	0.000352	CcSEcCtD
Desogestrel—Levonorgestrel—CYP3A4—prostate cancer	1.7e-05	0.0127	CrCbGaD
Desogestrel—Immune system disorder—Doxorubicin—prostate cancer	1.67e-05	0.000342	CcSEcCtD
Desogestrel—Gastrointestinal pain—Capecitabine—prostate cancer	1.67e-05	0.000341	CcSEcCtD
Desogestrel—Abdominal pain—Docetaxel—prostate cancer	1.66e-05	0.000341	CcSEcCtD
Desogestrel—Alopecia—Doxorubicin—prostate cancer	1.63e-05	0.000335	CcSEcCtD
Desogestrel—Mental disorder—Doxorubicin—prostate cancer	1.62e-05	0.000332	CcSEcCtD
Desogestrel—Urticaria—Capecitabine—prostate cancer	1.62e-05	0.000332	CcSEcCtD
Desogestrel—Abdominal pain—Capecitabine—prostate cancer	1.61e-05	0.00033	CcSEcCtD
Desogestrel—Vomiting—Etoposide—prostate cancer	1.61e-05	0.00033	CcSEcCtD
Desogestrel—Malnutrition—Doxorubicin—prostate cancer	1.61e-05	0.00033	CcSEcCtD
Desogestrel—Rash—Etoposide—prostate cancer	1.6e-05	0.000327	CcSEcCtD
Desogestrel—Dermatitis—Etoposide—prostate cancer	1.6e-05	0.000327	CcSEcCtD
Desogestrel—Headache—Etoposide—prostate cancer	1.59e-05	0.000325	CcSEcCtD
Desogestrel—Hypersensitivity—Docetaxel—prostate cancer	1.55e-05	0.000318	CcSEcCtD
Desogestrel—Danazol—CYP3A4—prostate cancer	1.55e-05	0.0116	CrCbGaD
Desogestrel—Nausea—Etoposide—prostate cancer	1.5e-05	0.000308	CcSEcCtD
Desogestrel—Hypertension—Epirubicin—prostate cancer	1.5e-05	0.000308	CcSEcCtD
Desogestrel—Hypersensitivity—Capecitabine—prostate cancer	1.5e-05	0.000307	CcSEcCtD
Desogestrel—Gastrointestinal pain—Prednisone—prostate cancer	1.48e-05	0.000304	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.47e-05	0.000301	CcSEcCtD
Desogestrel—Urticaria—Prednisone—prostate cancer	1.44e-05	0.000295	CcSEcCtD
Desogestrel—Diarrhoea—Docetaxel—prostate cancer	1.44e-05	0.000295	CcSEcCtD
Desogestrel—Abdominal pain—Prednisone—prostate cancer	1.44e-05	0.000294	CcSEcCtD
Desogestrel—Ethinyl Estradiol—CYP3A4—prostate cancer	1.43e-05	0.0107	CrCbGaD
Desogestrel—Diarrhoea—Capecitabine—prostate cancer	1.39e-05	0.000286	CcSEcCtD
Desogestrel—Nervous system disorder—Epirubicin—prostate cancer	1.39e-05	0.000285	CcSEcCtD
Desogestrel—Hypertension—Doxorubicin—prostate cancer	1.39e-05	0.000285	CcSEcCtD
Desogestrel—Skin disorder—Epirubicin—prostate cancer	1.38e-05	0.000282	CcSEcCtD
Desogestrel—Norethindrone—CYP3A4—prostate cancer	1.38e-05	0.0103	CrCbGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.36e-05	0.000279	CcSEcCtD
Desogestrel—Vomiting—Docetaxel—prostate cancer	1.34e-05	0.000274	CcSEcCtD
Desogestrel—Hypersensitivity—Prednisone—prostate cancer	1.34e-05	0.000274	CcSEcCtD
Desogestrel—Rash—Docetaxel—prostate cancer	1.33e-05	0.000272	CcSEcCtD
Desogestrel—Dermatitis—Docetaxel—prostate cancer	1.33e-05	0.000272	CcSEcCtD
Desogestrel—Headache—Docetaxel—prostate cancer	1.32e-05	0.00027	CcSEcCtD
Desogestrel—Vomiting—Capecitabine—prostate cancer	1.3e-05	0.000265	CcSEcCtD
Desogestrel—Nervous system disorder—Doxorubicin—prostate cancer	1.29e-05	0.000264	CcSEcCtD
Desogestrel—Rash—Capecitabine—prostate cancer	1.29e-05	0.000263	CcSEcCtD
Desogestrel—Dermatitis—Capecitabine—prostate cancer	1.28e-05	0.000263	CcSEcCtD
Desogestrel—Headache—Capecitabine—prostate cancer	1.28e-05	0.000261	CcSEcCtD
Desogestrel—Skin disorder—Doxorubicin—prostate cancer	1.28e-05	0.000261	CcSEcCtD
Desogestrel—Nausea—Docetaxel—prostate cancer	1.25e-05	0.000256	CcSEcCtD
Desogestrel—Diarrhoea—Prednisone—prostate cancer	1.24e-05	0.000254	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Epirubicin—prostate cancer	1.23e-05	0.000251	CcSEcCtD
Desogestrel—Nausea—Capecitabine—prostate cancer	1.21e-05	0.000248	CcSEcCtD
Desogestrel—Gastrointestinal pain—Epirubicin—prostate cancer	1.16e-05	0.000238	CcSEcCtD
Desogestrel—Vomiting—Prednisone—prostate cancer	1.15e-05	0.000236	CcSEcCtD
Desogestrel—Rash—Prednisone—prostate cancer	1.14e-05	0.000234	CcSEcCtD
Desogestrel—Dermatitis—Prednisone—prostate cancer	1.14e-05	0.000234	CcSEcCtD
Desogestrel—Headache—Prednisone—prostate cancer	1.14e-05	0.000233	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.13e-05	0.000232	CcSEcCtD
Desogestrel—Urticaria—Epirubicin—prostate cancer	1.13e-05	0.000231	CcSEcCtD
Desogestrel—Abdominal pain—Epirubicin—prostate cancer	1.12e-05	0.00023	CcSEcCtD
Desogestrel—Nausea—Prednisone—prostate cancer	1.08e-05	0.000221	CcSEcCtD
Desogestrel—Gastrointestinal pain—Doxorubicin—prostate cancer	1.07e-05	0.00022	CcSEcCtD
Desogestrel—Hypersensitivity—Epirubicin—prostate cancer	1.05e-05	0.000214	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—prostate cancer	1.04e-05	0.000214	CcSEcCtD
Desogestrel—Abdominal pain—Doxorubicin—prostate cancer	1.04e-05	0.000213	CcSEcCtD
Desogestrel—Diarrhoea—Epirubicin—prostate cancer	9.72e-06	0.000199	CcSEcCtD
Desogestrel—Hypersensitivity—Doxorubicin—prostate cancer	9.68e-06	0.000198	CcSEcCtD
Desogestrel—Vomiting—Epirubicin—prostate cancer	9.03e-06	0.000185	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—prostate cancer	8.99e-06	0.000184	CcSEcCtD
Desogestrel—Rash—Epirubicin—prostate cancer	8.95e-06	0.000183	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—prostate cancer	8.95e-06	0.000183	CcSEcCtD
Desogestrel—Headache—Epirubicin—prostate cancer	8.9e-06	0.000182	CcSEcCtD
Desogestrel—Nausea—Epirubicin—prostate cancer	8.44e-06	0.000173	CcSEcCtD
Desogestrel—Vomiting—Doxorubicin—prostate cancer	8.36e-06	0.000171	CcSEcCtD
Desogestrel—Rash—Doxorubicin—prostate cancer	8.29e-06	0.00017	CcSEcCtD
Desogestrel—Dermatitis—Doxorubicin—prostate cancer	8.28e-06	0.000169	CcSEcCtD
Desogestrel—Headache—Doxorubicin—prostate cancer	8.23e-06	0.000169	CcSEcCtD
Desogestrel—Nausea—Doxorubicin—prostate cancer	7.81e-06	0.00016	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	7.26e-06	0.0004	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—HSPA1A—prostate cancer	7.17e-06	0.000395	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR2—prostate cancer	7.17e-06	0.000395	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PLXNB1—prostate cancer	7.14e-06	0.000394	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	7.11e-06	0.000392	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LPAR1—prostate cancer	7.06e-06	0.000389	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GRP—prostate cancer	7.06e-06	0.000389	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PLCB2—prostate cancer	6.99e-06	0.000385	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LRP2—prostate cancer	6.99e-06	0.000385	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—VDR—prostate cancer	6.94e-06	0.000383	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	6.92e-06	0.000382	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GRPR—prostate cancer	6.88e-06	0.000379	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	6.86e-06	0.000378	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—P4HB—prostate cancer	6.85e-06	0.000378	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CX3CL1—prostate cancer	6.85e-06	0.000378	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HIST1H2BG—prostate cancer	6.73e-06	0.000371	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—prostate cancer	6.7e-06	0.000369	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	6.7e-06	0.000369	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	6.68e-06	0.000368	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GRB7—prostate cancer	6.67e-06	0.000368	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PDE4D—prostate cancer	6.67e-06	0.000368	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL17RD—prostate cancer	6.64e-06	0.000366	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NCOA1—prostate cancer	6.61e-06	0.000364	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	6.55e-06	0.000361	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—EGFR—prostate cancer	6.52e-06	0.000359	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HIST1H4H—prostate cancer	6.5e-06	0.000358	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	6.37e-06	0.000351	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GNG5—prostate cancer	6.34e-06	0.00035	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AR—prostate cancer	6.34e-06	0.000349	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—DNMT3B—prostate cancer	6.31e-06	0.000348	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—RXRA—prostate cancer	6.29e-06	0.000346	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—NR3C1—prostate cancer	6.25e-06	0.000344	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	6.2e-06	0.000342	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	6.19e-06	0.000341	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RPL10—prostate cancer	6.19e-06	0.000341	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KRAS—prostate cancer	6.16e-06	0.000339	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—HIST1H2BG—prostate cancer	6.07e-06	0.000335	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	6.04e-06	0.000333	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—WNT4—prostate cancer	5.92e-06	0.000326	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JUP—prostate cancer	5.92e-06	0.000326	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NPPA—prostate cancer	5.87e-06	0.000323	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—HIST1H4H—prostate cancer	5.87e-06	0.000323	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—PPARA—prostate cancer	5.85e-06	0.000323	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—SIRT1—prostate cancer	5.78e-06	0.000318	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MED12—prostate cancer	5.77e-06	0.000318	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—VDR—prostate cancer	5.69e-06	0.000314	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PIK3CA—prostate cancer	5.66e-06	0.000312	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MC2R—prostate cancer	5.65e-06	0.000311	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RALBP1—prostate cancer	5.65e-06	0.000311	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	5.55e-06	0.000306	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	5.54e-06	0.000305	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTHLH—prostate cancer	5.53e-06	0.000305	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TGFBR1—prostate cancer	5.53e-06	0.000305	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—prostate cancer	5.5e-06	0.000303	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKR1C3—prostate cancer	5.44e-06	0.0003	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	5.43e-06	0.000299	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PRKACB—prostate cancer	5.41e-06	0.000298	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PPP3CA—prostate cancer	5.27e-06	0.000291	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—THBS1—prostate cancer	5.27e-06	0.000291	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ERCC2—prostate cancer	5.21e-06	0.000287	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ANXA1—prostate cancer	5.19e-06	0.000286	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	5.13e-06	0.000283	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NR3C1—prostate cancer	5.12e-06	0.000282	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PRKCZ—prostate cancer	5.1e-06	0.000281	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PENK—prostate cancer	5.03e-06	0.000277	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IL6—prostate cancer	5.01e-06	0.000276	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGFR4—prostate cancer	4.92e-06	0.000271	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PARP1—prostate cancer	4.92e-06	0.000271	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RPS19—prostate cancer	4.91e-06	0.00027	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CALCA—prostate cancer	4.86e-06	0.000268	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PPARA—prostate cancer	4.8e-06	0.000265	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GHR—prostate cancer	4.8e-06	0.000265	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL12—prostate cancer	4.75e-06	0.000262	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	4.71e-06	0.00026	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—MYC—prostate cancer	4.7e-06	0.000259	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—DNMT1—prostate cancer	4.69e-06	0.000258	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—CREBBP—prostate cancer	4.65e-06	0.000256	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	4.65e-06	0.000256	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—AKT1—prostate cancer	4.62e-06	0.000255	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NCOA2—prostate cancer	4.6e-06	0.000254	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NRP1—prostate cancer	4.6e-06	0.000254	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.56e-06	0.000251	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—EZH2—prostate cancer	4.54e-06	0.00025	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CASP9—prostate cancer	4.47e-06	0.000247	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PARP1—prostate cancer	4.45e-06	0.000245	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—SERPINE1—prostate cancer	4.36e-06	0.00024	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR1—prostate cancer	4.35e-06	0.00024	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NGFR—prostate cancer	4.34e-06	0.000239	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PRKCQ—prostate cancer	4.34e-06	0.000239	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAP3K7—prostate cancer	4.28e-06	0.000236	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VIP—prostate cancer	4.28e-06	0.000236	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GNRH1—prostate cancer	4.28e-06	0.000236	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ESR2—prostate cancer	4.21e-06	0.000232	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—HSPA1A—prostate cancer	4.21e-06	0.000232	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GRP—prostate cancer	4.14e-06	0.000228	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LPAR1—prostate cancer	4.14e-06	0.000228	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGF10—prostate cancer	4.12e-06	0.000227	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PLCB2—prostate cancer	4.1e-06	0.000226	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LRP2—prostate cancer	4.1e-06	0.000226	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ADRB2—prostate cancer	4.08e-06	0.000225	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—P4HB—prostate cancer	4.02e-06	0.000222	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CX3CL1—prostate cancer	4.02e-06	0.000222	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VAV3—prostate cancer	3.98e-06	0.000219	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIST1H2BG—prostate cancer	3.95e-06	0.000218	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TGFBR2—prostate cancer	3.92e-06	0.000216	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GRB7—prostate cancer	3.91e-06	0.000216	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PDE4D—prostate cancer	3.91e-06	0.000216	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NCOA1—prostate cancer	3.88e-06	0.000214	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ITPR1—prostate cancer	3.86e-06	0.000213	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.85e-06	0.000212	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIST1H4H—prostate cancer	3.81e-06	0.00021	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—CREBBP—prostate cancer	3.81e-06	0.00021	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GNG5—prostate cancer	3.72e-06	0.000205	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AR—prostate cancer	3.72e-06	0.000205	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RXRA—prostate cancer	3.69e-06	0.000203	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1R—prostate cancer	3.69e-06	0.000203	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—SERPINE1—prostate cancer	3.58e-06	0.000197	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LPL—prostate cancer	3.53e-06	0.000195	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PDGFRB—prostate cancer	3.5e-06	0.000193	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ITGB3—prostate cancer	3.41e-06	0.000188	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SIRT1—prostate cancer	3.39e-06	0.000187	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—VDR—prostate cancer	3.34e-06	0.000184	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB3—prostate cancer	3.31e-06	0.000182	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGFR2—prostate cancer	3.31e-06	0.000182	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTHLH—prostate cancer	3.24e-06	0.000179	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TGFBR1—prostate cancer	3.24e-06	0.000179	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKR1C3—prostate cancer	3.19e-06	0.000176	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PRKACB—prostate cancer	3.17e-06	0.000175	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TERT—prostate cancer	3.17e-06	0.000175	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PPP3CA—prostate cancer	3.09e-06	0.000171	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—THBS1—prostate cancer	3.09e-06	0.000171	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ERCC2—prostate cancer	3.06e-06	0.000168	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ANXA1—prostate cancer	3.05e-06	0.000168	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HIF1A—prostate cancer	3.03e-06	0.000167	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NR3C1—prostate cancer	3.01e-06	0.000166	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PRKCZ—prostate cancer	2.99e-06	0.000165	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LEP—prostate cancer	2.96e-06	0.000163	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CAV1—prostate cancer	2.94e-06	0.000162	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KDR—prostate cancer	2.9e-06	0.00016	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGFR4—prostate cancer	2.89e-06	0.000159	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PARP1—prostate cancer	2.89e-06	0.000159	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CALCA—prostate cancer	2.85e-06	0.000157	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ESR1—prostate cancer	2.83e-06	0.000156	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PPARA—prostate cancer	2.82e-06	0.000155	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL12—prostate cancer	2.79e-06	0.000154	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—BAD—prostate cancer	2.76e-06	0.000152	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—MYC—prostate cancer	2.76e-06	0.000152	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—APC—prostate cancer	2.67e-06	0.000147	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CG—prostate cancer	2.67e-06	0.000147	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGF—prostate cancer	2.64e-06	0.000146	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IRS1—prostate cancer	2.64e-06	0.000146	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CASP9—prostate cancer	2.63e-06	0.000145	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GSK3B—prostate cancer	2.57e-06	0.000141	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PRKCQ—prostate cancer	2.54e-06	0.00014	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NGFR—prostate cancer	2.54e-06	0.00014	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—INS—prostate cancer	2.53e-06	0.000139	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAP3K7—prostate cancer	2.51e-06	0.000139	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CREBBP—prostate cancer	2.48e-06	0.000137	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1—prostate cancer	2.45e-06	0.000135	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGF10—prostate cancer	2.42e-06	0.000133	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ADRB2—prostate cancer	2.39e-06	0.000132	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAP2K1—prostate cancer	2.37e-06	0.00013	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CD—prostate cancer	2.35e-06	0.00013	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VAV3—prostate cancer	2.33e-06	0.000129	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SERPINE1—prostate cancer	2.32e-06	0.000128	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TGFBR2—prostate cancer	2.3e-06	0.000127	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ITPR1—prostate cancer	2.26e-06	0.000125	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MYC—prostate cancer	2.26e-06	0.000125	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGF2—prostate cancer	2.25e-06	0.000124	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—CREBBP—prostate cancer	2.24e-06	0.000123	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NOS3—prostate cancer	2.22e-06	0.000122	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1R—prostate cancer	2.16e-06	0.000119	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—JAK2—prostate cancer	2.16e-06	0.000119	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MDM2—prostate cancer	2.11e-06	0.000116	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SERPINE1—prostate cancer	2.1e-06	0.000116	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB2—prostate cancer	2.08e-06	0.000114	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LPL—prostate cancer	2.07e-06	0.000114	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PDGFRB—prostate cancer	2.06e-06	0.000113	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CB—prostate cancer	2.05e-06	0.000113	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ITGB3—prostate cancer	2e-06	0.00011	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL8—prostate cancer	1.97e-06	0.000109	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB3—prostate cancer	1.94e-06	0.000107	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGFR2—prostate cancer	1.94e-06	0.000107	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1B—prostate cancer	1.92e-06	0.000106	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CASP3—prostate cancer	1.88e-06	0.000104	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL2—prostate cancer	1.88e-06	0.000104	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TERT—prostate cancer	1.86e-06	0.000103	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCND1—prostate cancer	1.83e-06	0.000101	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CTNNB1—prostate cancer	1.82e-06	0.0001	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HIF1A—prostate cancer	1.78e-06	9.82e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MMP9—prostate cancer	1.78e-06	9.81e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1A—prostate cancer	1.77e-06	9.78e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—prostate cancer	1.77e-06	9.76e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LEP—prostate cancer	1.74e-06	9.58e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CAV1—prostate cancer	1.72e-06	9.5e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KDR—prostate cancer	1.7e-06	9.39e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EP300—prostate cancer	1.69e-06	9.31e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SRC—prostate cancer	1.64e-06	9.05e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BAD—prostate cancer	1.62e-06	8.93e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VEGFA—prostate cancer	1.6e-06	8.81e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STAT3—prostate cancer	1.58e-06	8.73e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—APC—prostate cancer	1.57e-06	8.65e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CG—prostate cancer	1.57e-06	8.65e-05	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AKT1—prostate cancer	1.57e-06	8.65e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IRS1—prostate cancer	1.55e-06	8.55e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGF—prostate cancer	1.55e-06	8.55e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GSK3B—prostate cancer	1.51e-06	8.3e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—INS—prostate cancer	1.49e-06	8.19e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MYC—prostate cancer	1.47e-06	8.11e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TGFB1—prostate cancer	1.47e-06	8.09e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CREBBP—prostate cancer	1.45e-06	8.02e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGFR—prostate cancer	1.44e-06	7.93e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1—prostate cancer	1.44e-06	7.92e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAP2K1—prostate cancer	1.39e-06	7.65e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CD—prostate cancer	1.38e-06	7.6e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SERPINE1—prostate cancer	1.36e-06	7.52e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KRAS—prostate cancer	1.36e-06	7.49e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MYC—prostate cancer	1.33e-06	7.32e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGF2—prostate cancer	1.32e-06	7.28e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOS3—prostate cancer	1.3e-06	7.18e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JAK2—prostate cancer	1.27e-06	6.98e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CA—prostate cancer	1.25e-06	6.88e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MDM2—prostate cancer	1.24e-06	6.81e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB2—prostate cancer	1.22e-06	6.72e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—prostate cancer	1.21e-06	6.66e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CB—prostate cancer	1.2e-06	6.63e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL8—prostate cancer	1.16e-06	6.37e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1B—prostate cancer	1.13e-06	6.22e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CASP3—prostate cancer	1.11e-06	6.1e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL6—prostate cancer	1.11e-06	6.1e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL2—prostate cancer	1.1e-06	6.09e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCND1—prostate cancer	1.08e-06	5.93e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CTNNB1—prostate cancer	1.07e-06	5.88e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP9—prostate cancer	1.05e-06	5.76e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1A—prostate cancer	1.04e-06	5.74e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—prostate cancer	1.04e-06	5.73e-05	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT1—prostate cancer	1.02e-06	5.62e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EP300—prostate cancer	9.91e-07	5.46e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SRC—prostate cancer	9.64e-07	5.31e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFA—prostate cancer	9.38e-07	5.17e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STAT3—prostate cancer	9.29e-07	5.12e-05	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AKT1—prostate cancer	9.21e-07	5.08e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MYC—prostate cancer	8.63e-07	4.76e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TGFB1—prostate cancer	8.61e-07	4.75e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGFR—prostate cancer	8.45e-07	4.65e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KRAS—prostate cancer	7.98e-07	4.4e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CA—prostate cancer	7.33e-07	4.04e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—prostate cancer	7.09e-07	3.91e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL6—prostate cancer	6.49e-07	3.58e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT1—prostate cancer	5.99e-07	3.3e-05	CbGpPWpGaD
